Abstract
Introduction
Chk1 is a conserved protein kinase. It was originally identified in fission yeast [1] [2, 3] . The involvement of Chk1 protein kinase in transducing DNA damage signals and its requirement for both S phase and G2/M checkpoint has been elucidated but few experimental evidence has recently connected Chk1 to the mitotic spindle checkpoint. This checkpoint ensures proper chromosome segregation by delaying anaphase until chromosomes are aligned on the spindle thus preventing chromosomal instability, aneuploidy and cancer predisposition [4] .
and its role was then largely confirmed in vertebrate cells as a protein kinase required to delay entry of cells with damaged or unreplicated DNA into mitosis
It has been recently proposed that Chk1 is needed in metaphase for proper chromosome alignment on the equatorial planes, as shown by a pronounced block in mitosis of Chk1-depleted HeLa cells [5] . Chk1-deficient cells also fail to sustain mitotic arrest after treatment with taxol, which stabilizes microtubules, but do arrest in response to nocodazole (Noc), suggesting that Chk1 helps to sustain anaphase delay when chromosome biorientation is disrupted [6] .
Although the role of Chk1 in DNA damage response has been largely clarified, its role during normal cell cycle progression remains controversial. Chk1 -/-mice die at E6.5 days [2] indicating its fundamental role in early embryonic development. Corroborating this, a conditional KO of Chk1 induced apoptosis in embryonic mice stem cells [7] and led to premature mitosis before completion of DNA replication and cell death by mitotic catastrophe [8] . However, evidence on the role of Chk1 in somatic cancer and in normal cell lines and tissues is controversial. The only available vertebrate Chk1 KO somatic cancer cellular system, the DT40 avian lymphoma cell line Chk1-/-, is viable despite multiple checkpoint and survival defects [9] . These data are in agreement with what has been reported in various human cancer cell lines where Chk1 depletion by siRNA did not alter the cell cycle profile or induce apoptosis in the absence of DNA damage [10, 11] 
. In contrast, Chk1 is essential for growth of mammary proliferating epithelial cells and a strong phenotype was observed in heterozygosity with general mis-coordination of the cell cycle due to inappropriate S phase entry, accumulation of DNA damage during replication and failure to restrain mitotic entry

U2OS cells lacking Chk1 undergo aberrant mitosis and fail
to activate the spindle checkpoint [12] . Similar [10, 11] and with the data showed in Fig. 2 , reporting that Chk1 depletion did not alter the cell proliferation and the cell cycle profile in various human cancer cell lines (Fig. 2 ).
Materials and methods
Cell culture and transfection
FACS analysis
Results
U2OS cells lacking Chk1 show proliferation defects and alteration of the cell cycle profile
1C). Cell cycle analysis showed an increase in the amount of cells in S and G2/M phases 72 hrs after transfection (Fig. 1D). The effects of Chk1 depletion in U2OS cells are different if compared with previous data
Chk1 depletion in U2OS cells leads to accumulation of cells with 4N DNA content but not of mitotic cells
To better define the nature of the accumulation of U2OS cells lacking Chk1 in S and G2/M phases of the cell cycle, we analysed the cyclin B1 levels by FACS. Cyclin B1 is specifically expressed in late S phase and is degraded by E3 ubiquitin ligase activity before
anaphase [4] . Efficient depletion of Chk1 72 hrs after siRNA transfection was confirmed by Western blot analysis (Fig. 3A) 
Chk1-depleted U2OS cells show an accumulation of abnormal micro-polynucleated cells that leads to cell death by a predominantly apoptosis independent mechanism
To investigate whether the lack of proliferation of Chk1-depleted cells was due to apoptosis, sulforodamine/DAPI staining was done. We observed both clearly apoptotic (thin arrow, Fig. 4A (Fig. 5A, lower panel) . In addition, these same cells showed an Aurora B positive signal in the region corresponding to the chromosome bridge (Fig. 5B) 
leading to accumulation of tetraploid cells in G1. Concurrent with this, we also observed high levels of p53 and p21 and phosphorylation in ser 15 residue of p53 in the siRNA Chk1 transfected cells 72 hrs after transfection (at which time there was clear accumulation of 4N DNA content), suggesting that the G1 tetraploid block may occur through p53-dependent activation of p21 (Fig. 5C). Transfection of U2OS cells with a second siRNA directed against a different Chk1 siRNA target confirmed the results just described (data not shown) thus suggesting that the effect observed is specific and uniquely attributable to the lack of Chk1.
Chk1-depleted U2OS cells are unable to arrest in mitosis following spindle disruption by nocodazole
To investigate whether the abnormal phenotype in Chk1-depleted U2OS cells was the consequence of a defect in the spindle checkpoint, U2OS cells transfected with either scramble or siRNA Chk1 were treated with 75 nM of Noc at 48 hrs after transfection for 20 hrs, then washed and incubated in Noc-free medium for another 7 hrs. As shown in Fig. 6A, after 20 hrs of Noc treatment, most of the siRNA scramble transfected cells had rounded up having the typical mitotic morphology, which it was not observed in the siRNA Chk1 transfected cells. To quantify the cells in mitosis, cells treated or not with Noc were stained with phospho-H3 and analysed by IF. As shown in Fig. 6B, less than 2.5% of asynchronous untreated cells transfected with either scramble or Chk1 siRNA appeared phospho-H3 positive. However, 20 hrs of Noc induced an obvious accumulation of cells in mitosis in siRNA scramble transfected cells (approximately 40%) whereas the proportion of mitotic cells in Chk1-depleted cells treated with Noc was much lower (approximately 10%). At 7 hrs after Noc release, the U2OS siRNA scramble transfected cells had completely re-entered the cell cycle, exiting from the mitotic block. At this time-point,
Fig. 4 Chk1-depleted cells die by a mechanism predominantly apoptosis independent (A) Sulforodamine-DAPI staining of U2OS cells 72 hrs after siRNA transfection. The thin yellow arrow indicates a typical apoptotic morphology and the thick one points to a polynucleated cell. (B) Lamin B and DAPI staining in U2OS cells 72 hrs after transfection. The thin white arrows show the breaking down nuclear envelopes in apoptotic cells and the thicker one points to the intact nuclear envelope of a micronucleated cell. (C) Bi-parametric forward scatter/caspase-3-PE analysis in U2OS cells evaluated at 72 and 96 hrs after transfection. The amount of viable cells is represented by the gate R1. U2OS cells treated with staurosporine (A) were included in the experiment as positive control (percentage of viable cells in positive control sample: 24.17%).
fewer than 2% of siRNA Chk1 transfected cells were in mitosis both with and without Noc treatment. Figure 6C shows (Fig. 6B) , together with the cell cycle analysis (shown in Fig. 6C ), strongly suggests that the Chk1-depleted cells with the G2/M DNA content is not related to a Noc-induced mitotic arrest.
To corroborate this finding, we analysed the expression of cyclin B1, a mitotic cyclin and cyclin E, a G1 cyclin, by Western blot (Fig. 6D) (Fig. 6D) (Fig. 6D, lower part) . Geminin fluctuates throughout the cell cycle with its levels lowest at G1 and consistently elevated in S and G2. It is degraded by the anaphase-promoting complex (APC) in mitosis [15] [16] . Our data suggest that Chk1 depletion causes U2OS to fail to activate the spindle checkpoint induced by unattached kinetochores.
. As expected, cyclin B1 accumulated in scramble siRNA transfected cells 20 hrs after Noc treatment (Figs. 6D
Fig. 5 Phenotypical characterization of siRNA Chk1 transfected U2OS cells. (A) DAPI staining of U2OS cells 72 hrs after transfection with siRNA Chk1. The upper panels (a) give two examples of the massive presence of the micropolynucleated phenotype and the lower panels (b) show micropolynucleated cells appearing at the last stage of cytokinesis with nuclei still attached. (B) Aurora B and DAPI staining of U2OS cells 72 hrs after siRNAs transfection. The white arrows indicate the Aurora B signal in the corresponding chromosome bridge of dividing cells (white circle). (C) Western blot analysis of Chk1, p-ser15 p53, p53, p21 and actin protein levels of U2OS cells 72 hrs after siRNAs transfection. and 7A). No accumulation of cyclin B1 was detected in any other scramble or Chk1 siRNA transfected samples treated or not with Noc
Fig. 6 Effects of nocodazole in siRNA scramble or siRNA Chk1 transfected U2OS cells. (A) DIC microscopy pictures of control and Noc treated (20 hrs 75 nM), scramble and Chk1 siRNA transfected U2OS cells. (B) Mitotic index analysis of cells either treated (+) or not (-) with Noc (released 0 and 7 hrs after 20 hrs of treatment 75 nM). Cells were fixed with paraformaldehyde and stained with the phospho-H3 antibody and DAPI. The data are the mean ± S.D. of three independent experiments. The percentage of phospho-H3 positive cells was calculated on at least 300 cells. (C) FACS analysis showing the DNA profile at the start of Noc treatment (48 hrs after transfection), at the end, and 7 hrs after Noc release. (D) Western blot analysis of Chk1, cyclinB1, cyclinE, p53, p21, geminin and Ran protein levels at the end and 7 hrs after 20 hrs of Noc treatment. Geminin and its relative Ran were detected on a different SDS-PAGE (lower panel).
Possible requirement of Chk1 in U2OS cells to activate the mitotic spindle checkpoint proteins Mad2 and BubR1
To investigate the molecular mechanisms of the accumulation of morphologically abnormal G1 tetraploid cells after Chk1 depletion, and the lack of mitotic arrest in these cells after Noc treatment, we examined the protein levels of two of the principal components of the mitotic spindle checkpoint Mad2 and BubR1 [17] . Mad2 and BubR1 protein levels were lower in the Chk1-depleted cells 72 hrs after siRNA Chk1 transfection than in siRNA scramble transfected cells. Chk1 depletion also prevented the accumulation of these proteins following Noc treatment. BubR1 phosphorylation after Noc was also absent in the Chk1-depleted cells (Fig. 7A) . Figure 7B  shows [4, 20] . The APC is inhibited by preventing its association with Cdc20 [17, 20] . This requires both the checkpoint proteins Mad2 and BubR1, which inhibit the APC whenever a misaligned or unattached chromosome is detected, thus arresting cells at the metaphaseanaphase transition [4, 17] 
